vimarsana.com

Page 26 - எழுந்திரு காடு பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Could a Placebo Become the Next Big ED Treatment?

email article Regulators in Europe are close to approving an unusual over-the-counter treatment for erectile dysfunction (ED): a non-medicated gel that once was used as a placebo, but turned out to work just as well as the agent that was actually being tested. Meanwhile, the FDA just gave the OK for a trial of the treatment to start. Research has suggested that the gel can spur erections within minutes in some patients after it is applied to the head of the penis. If it actually works, the gel technically a medical device, not a drug could be the biggest advance in ED since the advent of Viagra-type drugs in the late 1990s and early 2000s.

Work begins on planned $450M tower at Wake Forest Baptist

Work begins on planned $450M tower at Wake Forest Baptist
journalnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalnow.com Daily Mail and Mail on Sunday newspapers.

Kidney Patients And Docs Ask Congress To Expand Research And Innovation

Kidney Patients And Docs Ask Congress To Expand Research And Innovation Amidst COVID-19, Largest American Kidney Organizations Back Strategic Funding for NIH and KidneyX News provided by Share this article Share this article WASHINGTON, April 16, 2021 /PRNewswire/ The American Association of Kidney Patients (AAKP), the largest kidney patient organization in America, partnered with the American Society of Nephrology (ASN), the world s largest renal professional organization, to host their 9 th Annual Kidney Health Advocacy Day on April 14th. The event centered on two specific Congressional kidney funding requests, $25 million for the KidneyX, a collaborative between ASN and the U.S. Department of Health and Human Services (HHS), and an additional $285 million for the National Institutes of Health (NIH), each designed to accelerate groundbreaking advances in kidney disease research and innovation. Together, the organizations conducted dozens of joint, virtual meetings among key

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.